Folivane-Plus

Quick links to important sections

Folivane-Plus

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Folivane-Plus

Property Description
Active Ingredient Iron, Folic Acid, Vitamin C, B-Complex
Form Oral Capsule
Pharmacological Class Vitamin and Mineral Combination / Iron Product
Origin Nutritional Supplement (Often prescription-grade)

What Type of Product is Folivane-Plus? (Core Identity & Class)

Folivane-Plus is a combination nutritional supplement, typically provided in an oral capsule form. It is a Dietary Supplement, belonging to the high-level pharmacological class of Vitamin and Mineral Combinations and Iron Products. Its distinctive feature is its specific combination of iron salts (Ferrous Fumarate and Polysaccharide Iron Complex) to enhance absorption and tolerance. As an oral product, its route of administration is designed for systemic absorption through the digestive tract.


Key Ingredients: The Combination of Iron, Folate, and Vitamins

Folivane-Plus contains a targeted mixture of Iron, Folic Acid, Ascorbic Acid (Vitamin C), and a comprehensive B-Vitamin complex. The primary active ingredients are Iron and Folic Acid (Vitamin B9). The formulation is clinically recognized for its synergistic effect; Vitamin C (Ascorbic Acid) is a powerful enhancer of nonheme iron absorption in the gut. This means Vitamin C helps your body get the most out of the iron you consume. This comprehensive approach supplies essential co-factors, including the full B-Vitamin complex (B1, B2, B6, B12), necessary for the body to utilize the iron and folate effectively.


General Purpose: Supporting Blood Health and Nutritional Status

The general purpose of Folivane-Plus is to maintain or improve the nutritional status of individuals who are known to have deficiencies in these specific vitamins and minerals. Its action principle is supportive: Iron is essential for forming hemoglobin, while Folic Acid and Vitamin B12 are necessary co-factors for the healthy production and maturation of red blood cells. By supplying these micronutrients, the product helps ensure that your body has the building blocks for healthy blood. A typical use scenario involves helping individuals recover and maintain nutrient balance after periods of depletion.

Regulatory References

  1. MedlinePlus

What side effects are possible with Folivane-Plus?

Possible side effects and safety information: Folivane-Plus

Folivane-Plus, as a combination iron and vitamin product, has a safety profile defined by expected gastrointestinal effects and critical regulatory constraints related to its active ingredients. Adverse reactions are classified primarily within Gastrointestinal Disorders.


Adverse Reaction Frequencies

The most frequent adverse reactions are related to the iron component and are often classified as Common in regulatory documents, affecting up to 1 in 10 people. These include nausea, constipation, diarrhea, and abdominal discomfort. A common, expected, and harmless result of oral iron therapy is the darkening of stools. Rare adverse reactions include hypersensitivity events such as skin rash or pruritus.


Serious Safety Constraints and Risks

The official labeling for iron-containing products mandates critical warnings regarding the risk of accidental fatal iron poisoning in young children. This is considered the most serious non-dose-related risk. Furthermore, the product is contraindicated in patients with established iron overload conditions such as Hemochromatosis, as documented by regulatory agencies.


Population-Specific Safety and Timing

For the folate component, a crucial safety constraint exists: its use is restricted in patients with untreated Vitamin B12 deficiency (Pernicious Anemia) because folic acid may mask the progression of neurological damage while correcting blood parameters. Regarding timing, the common gastrointestinal side effects are often reported as more prominent during the initial phase of therapy.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Folivane-Plus is defined by the acute toxicity risk of its Iron component. Overdose manifests initially with severe gastrointestinal disturbances, including vomiting, diarrhea, abdominal pain, hematemesis (bloody vomiting), and hypotension (low blood pressure). This is documented to potentially progress to severe systemic effects.

Life-Threatening Risks and Emergency Actions

The most serious documented risk is fatal poisoning in children under 6 years of age, making accidental ingestion a medical emergency. In severe cases, the overdose profile includes life-threatening outcomes such as circulatory collapse, seizures, coma, and delayed acute hepatic failure (liver damage).

Emergency medical attention must be sought immediately for any suspected overdose or accidental ingestion.

Regulatory documents outline that professional management requires urgent hospital monitoring, including measurement of serum iron levels, and administration of supportive care. The specific chelating agent Deferoxamine is indicated for the treatment of severe systemic iron intoxication, as described in official prescribing information.

Therapeutic Uses of Folivane-Plus

What Folivane-Plus Treats: Main Uses and Benefits

Folivane-Plus is primarily used to address symptoms related to systemic imbalance, specifically deficiencies in iron and folate that lead to anemia, such as iron deficiency anemia and nutritional megaloblastic anemia. The therapeutic approach aligns with general guidelines for deficiency treatment. The supplement is commonly used across therapeutic domains where additional symptomatic support is needed.

It helps address symptom clusters of profound systemic fatigue and generalized weakness which interfere with daily functioning. Beyond addressing deficiencies, it is relevant in contexts of heightened physiological demands, including prenatal care, the postnatal period, and in cases of chronic nutritional depletion. The folate component is commonly used to help with managing the risk of specific developmental anomalies, such as neural tube defects (NTDs), in relevant populations. This supportive benefit contributes to easing the overall symptom load and helps improve day-to-day comfort during symptomatic periods.

“The primary purpose of this approach is to provide supportive relief when symptoms interfere with routine activities.”


Quick Fact: Relevant for Anemia-Related Fatigue

Eligibility and Restrictions for Use

Folivane-Plus is a prescription nutritional supplement whose eligibility is defined by regulatory guidelines, focusing on age, underlying conditions, and iron sensitivity.

Eligibility Scope

Populations for whom use is allowed (as stated in label):

  • Adults with certain illnesses or vitamin deficiencies.
  • Children over 12 years of age (included in the standard use population).
  • Pregnant and Lactating Women for nutritional support.

Populations for whom use is contraindicated:

  • Patients with known hypersensitivity to any ingredient.
  • Patients with Hemosiderosis or Hemochromatosis (iron overload disorders).
  • Patients with Hemolytic Anemias.
  • Patients with Pernicious Anemia (as the Folic Acid content may obscure the condition’s diagnosis).

Age-related eligibility rules:

  • Children Under 12 Years of Age: DO NOT ADMINISTER to this age group.
  • Pediatric and Elderly Patients: Safety and effectiveness have not been established in general pediatric patients or elderly patients.

Eligibility-related restrictions:

  • Use is not recommended for patients receiving Levodopa due to an officially documented drug interaction risk.
  • Folic acid alone is improper therapy in treating megaloblastic anemias where Vitamin B12 deficiency is present, due to the risk of masking the diagnosis.

Resulting Eligibility Structure

The official regulatory documents define the eligibility through absolute contraindications for conditions of iron overload and the specific diagnostic risk Folic Acid poses with Pernicious Anemia. Use is permitted for adults and adolescents (12 and older) and is often indicated during pregnancy and lactation, while explicit restrictions apply to children under 12.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents define the interaction profile of Folivane-Plus (Iron, Folic Acid, B-Complex) primarily through effects on absorption and metabolism.

Documented Exposure-Altering Interactions

The iron component is officially known to decrease the absorption of certain co-administered medicinal products, which requires mandatory timing separation. This reduction in exposure is documented with product classes including Tetracycline and Quinolone Antibiotics (e.g., Ciprofloxacin), and the thyroid hormone Levothyroxine. Heartburn medications (Antacids, PPIs) are officially stated to decrease the absorption of the iron component.

Pharmacodynamic and Metabolic Constraints

The Folic Acid component may officially decrease the blood levels of the anti-seizure medication Phenytoin by altering its metabolism. The Pyridoxine (Vitamin B6) component is officially not recommended for use with the anti-Parkinsonian agent Levodopa due to the potential for antagonism of effect. Folic acid doses over 0.1 mg are officially contraindicated in cases of undiagnosed Vitamin B12 deficiency.

Administration Timing and Substance Constraints

Administration of the iron component requires separation by at least 4 hours from Levothyroxine and at least 2 to 6 hours from various Antibiotics and Antacids. Alcohol consumption is officially noted as a population constraint, as it may increase folic acid elimination, potentially requiring an adjustment to the daily intake.

Mechanism of Action

Folivane-Plus operates strictly as a substrate and co-factor replenishment mechanism, targeting the core biochemical processes of hematopoiesis (blood cell formation). Its action is systemic and focused on providing the necessary molecular components required for cellular function and proliferation.

Mechanism for Iron Bioavailability and Intestinal Transport

This domain covers the critical initial step where Ascorbic Acid (Vitamin C) acts as a reducing agent for nonheme ferric iron, increasing its absorption via the Divalent Metal Transporter 1 ( DMT1) in the gut. This efficient transport delivers necessary elemental Iron substrate for systemic utilization.

Mechanism for DNA Synthesis and Red Blood Cell Maturation

This mechanism relies on the interlinked supply of Folic Acid and Vitamin B12, which function as essential co-factors for enzymes like Methionine Synthase. This synergy ensures the unimpeded metabolic flow required for stable DNA synthesis in erythroid precursor cells, which ensures the correct cellular division and structure of RBC precursors to ensure their final maturation.

Completing the Heme and Hemoglobin Production Cascade

The final systemic mechanism involves integrating the absorbed Iron into Protoporphyrin IX to form Heme, which subsequently assembles into Hemoglobin. The operation of this cascade, underpinned by all component nutrients, leads to the core physiological consequence: a measurable increase in the level of functional Hemoglobin, which results in increased systemic Oxygen Transport capacity.

Dosage and Administration Information

How to Use Folivane-Plus

The principles for using Folivane-Plus are structured around a fixed dosage and administration schedule. This section describes the high-level usage patterns without addressing therapeutic claims or safety information.


Official Administration Guidelines

Folivane-Plus is supplied as an oral capsule and is administered exclusively via the oral route. The standard usage pattern for the product is a single one (1) capsule dose, taken once daily, establishing a simple, non-complex regimen.


Contextual Usage Principles

The timing of administration is intended to optimize intake conditions. The capsule is generally taken between meals; however, it is specifically noted to be best absorbed when taken at bedtime. Administration may be taken after meals if deemed necessary to diminish occasional gastrointestinal disturbances, or as prescribed.


Population and Procedural Constraints

Standard usage is for adults and children over 12 years of age. The administration of Folivane-Plus is not recommended for children under the age of 12 due to the absence of established safety and effectiveness data for this pediatric population. All users are instructed not to exceed the recommended dosage, which ensures adherence to the standardized daily intake of 125 mg elemental iron and 1000 mcg of folic acid.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Folivane-Plus


Evidence for Anemia Related to Iron and Folate Deficiency

Research for the core components (iron and folic acid) relies on Randomized Controlled Trials (RCTs) and Systematic Reviews evaluated in non-pregnant adults and children with identified deficiencies. These studies examined the product's effect on hematological biomarkers like Hemoglobin concentration and Ferritin levels. The findings describe patterns observed in the studies consistent with measured increases in micronutrient levels in the observed populations. However, evidence quality varies; some trials reported that the co-administration of folic acid did not consistently lead to different hematological measurements compared to iron alone in cases where iron deficiency was the sole cause.


Evidence for Use in Pregnancy and Periconceptional Care

The supplement was evaluated in research exploring maternal and fetal health outcomes, specifically in pregnant women and women of childbearing age (periconceptional period). Research monitored maternal outcomes and infant/fetal outcomes related to the reported incidence of Neural Tube Defects (NTDs) and birth weight. The certainty remains low for several important maternal and infant outcomes, such as severe maternal anemia or neonatal death. Research highlights that trial heterogeneity means findings were mixed or varied across different regions.


Assessing Symptom Outcomes, Including Fatigue

The combination supplement was also studied for its use in patients experiencing symptoms like anemia-related systemic fatigue and generalized weakness. Researchers used functional measures and patient-reported symptomatic scales to monitor outcomes reflecting daily functioning. However, findings related to these symptom scales were mixed across different studies. The evidence level is limited regarding whether the supplement is associated with a measurable, consistent change in systemic fatigue or generalized weakness.


What Remains Uncertain in the Research Landscape

This summary highlights areas where information is still developing. Research indicates that data for certain groups remain insufficient, particularly for patients with specific comorbid conditions or those who are neither pregnant nor overtly anemic. Long-term effects are not fully established, and follow-up durations were limited in many trials, meaning the sustained status of micronutrient levels beyond the initial treatment period is not well characterized. Findings describe group patterns, not personal outcomes.

Key Studies & References

  1. MedlinePlus: Iron in diet (General Role of Iron and Folate in Blood Health)

Frequently Asked Questions (FAQ)

Common questions about Folivane-Plus (FAQ)


Q: Is Folivane-Plus a regular multivitamin or something stronger?

Folivane-Plus is classified in official documents as a prescription nutritional supplement, specifically categorized as a Vitamin and Mineral Combination/Iron Product. This classification distinguishes it from general, non-prescription multivitamin products typically available over the counter, reflecting its targeted and higher-dose formulation.


Q: What steps can be taken to reduce digestive side effects from Folivane-Plus?

Official directions note that the iron component can cause occasional gastrointestinal disturbances. To help diminish these effects, the product may be taken after a meal, although it is typically recommended between meals for optimal absorption.


Q: What research supports the effectiveness of the Folivane-Plus formulation?

Studies on the core components examine their effects on important hematological biomarkers, such as Hemoglobin and Ferritin levels, and have also explored outcomes related to maternal health. However, official reviews indicate that evidence for symptom-based outcomes, like relief from fatigue or weakness, is mixed or considered limited across different trials.


Q: Is the iron in Folivane-Plus better absorbed than standard iron supplements?

The official product mechanism highlights that the formulation includes Ascorbic Acid (Vitamin C), which functions as a reducing agent. This process is designed to increase the absorption of nonheme ferric iron via a specific intestinal pathway (the DMT1 transporter), promoting efficient systemic delivery.


Q: Why is taking Folivane-Plus between meals often recommended?

The capsule is generally recommended to be taken between meals or at bedtime. Official directions state this timing is preferred because the ingredients are best absorbed when the stomach is empty, allowing for maximum intake of the active components.


Q: What should I look out for if I'm taking a blood thinner and Folivane-Plus?

Regulatory documents indicate that the Pyridoxine (Vitamin B6) component in this product may interact with anticoagulant medications, which are commonly referred to as blood thinners (like aspirin or heparin). Appropriate timing separation or dose adjustments are factors often considered by healthcare providers when managing this potential interaction.


Q: Can Folivane-Plus cause skin flushing or redness?

While the label lists rare adverse reactions like skin rash, it also notes that components like Niacin (Vitamin B3) can cause cutaneous vasodilation. This effect, which may appear as skin flushing or redness, can sometimes be exacerbated by consuming alcohol.


Q: What happens if I accidentally take two Folivane-Plus capsules in one day?

Official instructions mandate that the recommended dosage must not be exceeded. Regulatory warnings emphasize that accidental overdose of products containing iron is a leading cause of fatal poisoning in young children and requires immediate contact with a healthcare provider or poison control center.


Q: Why does Folivane-Plus contain iron and folic acid together?

Folivane-Plus is a combination product designed to address multiple factors essential for healthy blood. Iron is the core component needed to form hemoglobin, while Folic Acid and Vitamin B12 act as necessary co-factors to support the healthy production and proper maturation of red blood cells (hematopoiesis).


Q: How does Folivane-Plus help with energy levels or fatigue?

The product's core mechanism is focused on increasing systemic oxygen transport capacity by improving Hemoglobin levels in the blood. While this is the physiological process that addresses anemia-related symptoms, studies focusing on patient-reported outcomes for general fatigue and energy levels have shown mixed or limited findings.


Q: Is Folivane-Plus the same as Folivane-F or Folivane-OB, or are they different?

Folivane-Plus is a distinct product formulation. While similar names suggest a related product family, Folivane-Plus often contains a specific, different composition of vitamins and minerals compared to formulations such as Folivane-F or Folivane-OB.


Q: Is it normal to have a bad taste in my mouth while taking this supplement?

Adverse reaction data indicates that an unpleasant or bad taste in the mouth has been reported by some users of this type of vitamin and mineral combination product.


Q: Are there any common over-the-counter medications that interact with Folivane-Plus?

Yes. Official interaction data specifies that heartburn medications, particularly antacids, can interfere with the absorption of the iron component. To ensure the supplement is effective, proper timing separation is necessary when taking antacids.


Q: Is it true that Folivane-Plus can interact with thyroid medications?

Yes, official documents confirm an interaction. The iron component is known to decrease the absorption of the thyroid hormone Levothyroxine (commonly used to treat low thyroid function), which requires a timing separation when taking both medicines.


Q: Can Folivane-Plus affect blood clotting, especially if I take aspirin?

Regulatory documents indicate that the Pyridoxine component may increase the possibility of bleeding in individuals taking anticoagulants. Because aspirin is often used for its blood-thinning effect, it falls within the scope of medications requiring monitoring for this interaction.


Q: Does Folivane-Plus interfere with any common laboratory blood tests?

Yes. Official precautions note that taking this medication may affect the results of certain laboratory blood tests. Users are instructed to inform their healthcare providers and any laboratory staff that they are taking Folivane-Plus.


Q: Can Folivane-Plus contribute to iron overload over a long period?

Official information explicitly contraindicates the use of this product in patients with existing iron overload conditions (such as Hemochromatosis). Secondary iron overload due to prolonged ingestion of iron supplements has been reported rarely, underscoring the importance of use under medical guidance.


Q: Are there any foods or drinks, like coffee or dairy, that should be avoided when taking Folivane-Plus?

Yes, to maximize absorption. Foods and beverages such as dairy products (milk, cheese), coffee, and tea are known to decrease the absorption of the iron component. Users are generally advised to avoid consuming these items within one to two hours of taking the product. Alcohol consumption may also increase the elimination of folic acid.


Q: Can Folivane-Plus interfere with the absorption of other oral medications?

Yes. The iron component in Folivane-Plus is officially known to decrease the absorption of other co-administered oral medications. This necessitates a mandatory timing separation, particularly with certain classes of antibiotics and thyroid hormones like Levothyroxine.


Q: Why does the Folivane-Plus formulation include multiple B vitamins besides folate and B12?

The formulation includes a comprehensive B-Vitamin complex (including B1, B2, and B6) to supply essential co-factors. These co-factors are needed to ensure the body can effectively utilize the primary components, iron and folate, during the complex biological process of forming and maturing red blood cells.


Q: How does the folic acid in Folivane-Plus differ from a lower dose over-the-counter folic acid?

Folivane-Plus contains 1000 mu g (1 mg) of Folic Acid per capsule. This is considered a therapeutic dose and is significantly higher than the amounts found in many common, general-purpose, over-the-counter multivitamin products.


Q: Will Folivane-Plus help if my vitamin deficiency is only B12?

Official cautions state that Folic Acid alone is considered an improper therapy for megaloblastic anemias caused solely by Vitamin B12 deficiency. The concern is that the folic acid may correct blood parameters, masking the progression of neurological damage caused by the untreated B12 deficiency.


Q: Does the biotin in Folivane-Plus affect my hair and nails?

While the primary regulatory focus is systemic function, official information advises patients to contact their prescriber if they notice unusual thinning of hair or brittle nails, which suggests these may be relevant clinical outcomes for Biotin's function.


Q: Does Folivane-Plus contain any ingredients that are common allergens?

The product is officially contraindicated for patients with a known hypersensitivity to any of its individual ingredients. Furthermore, official labeling notes that allergic sensitization has been reported following the administration of folic acid in some cases.

How should Folivane-Plus be stored and disposed of?

How to Store and Dispose of Folivane-Plus

Folivane-Plus must be stored under Controlled Room Temperature conditions, specifically between 20 C and 25 C (68 F to 77 F), as mandated by regulatory documents. Excursions are permitted only up to 30 C (86 F).

Protection and Container Requirements

Requirement Description (USP Standard)
Temperature Controlled Room Temperature.
Protection Store in a tight, light-resistant container.
Closure Must be dispensed with a child-resistant closure.

Child Safety and Disposal

The most critical storage instruction is the mandatory requirement to KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. This is necessary due to the severe risk of fatal iron poisoning in children. For disposal, the official labeling provides no universal instructions for discarding expired product, but strictly advises calling a doctor or poison control center immediately in case of accidental overdose.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Folivane-Plus found in:

A-Z Index: